Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report) has been given an average rating of 'Moderate Buy' by the nine research firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $44.09. A number of equities research analysts have weighed in on SGRY shares. Cantor Fitzgerald reaffirmed an 'overweight' rating and issued a $43.

https://www.dailypolitical.com/2023/09/23/surgery-partners-inc-nasdaqsgry-receives-44-09-consensus-price-target-from-brokerages.html

#dailypolitical